← Back to Search

Behavioural Intervention

Group 2 for Attention Deficit Disorder

N/A

Recruiting

Led By Caitlin Stamatis, PhD

Research Sponsored by Akili Interactive Labs, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Is 18 years of age or older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, day 42, day 84

Awards & highlights

Study Summary

"This trial aims to test a digital therapy called EndeavorOTC on university students to see if it can improve their cognitive and emotional health."

Who is the study for?

This study is for university students who may have attention issues or want to improve their cognitive functioning. Participants should be interested in trying a digital therapeutic called EndeavorOTC®.Check my eligibility

What is being tested?

The trial is testing the effects of a digital therapy app, EndeavorOTC®, on executive and cognitive functions in college students. It aims to see if this app can help with focus, memory, and other brain skills.See study design

What are the potential side effects?

Since EndeavorOTC® is a digital therapeutic (a type of treatment using software), it's not expected to have physical side effects like medication would. However, users might experience eye strain or headache from screen use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, day 42, day 84

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, day 42, day 84

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, day 42, day 84 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adult ADHD Self-Report Scale (ASRS)

Computerized Adaptive Test, Mental Health (CAT-MH®)

General Academic Self-Efficacy scale (GASE)

+4 more

Other outcome measures

System Usability Scale (SUS)

Trial Design

2Treatment groups

Experimental Treatment

Group I: Group 2Experimental Treatment1 Intervention

Participants receive 12-week access to EndeavorOTC 6-weeks after Group 1.

Group II: Group 1Experimental Treatment1 Intervention

Participants receive immediate 12-week access to EndeavorOTC.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Akili Interactive Labs, Inc.Lead Sponsor

16 Previous Clinical Trials

5,165 Total Patients Enrolled

Landmark CollegeUNKNOWN

Villa Maria CollegeUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are currently enrolled as participants in this clinical trial?

"Affirmative. The information available on clinicaltrials.gov confirms the ongoing patient recruitment for this medical investigation. Originally posted on January 10, 2024, with the latest update made on April 17, 2024, this study aims to enroll a total of 500 participants across two designated locations."

Answered by AI

Are potential participants currently able to apply for this ongoing medical study?

"Affirmative. Information available on clinicaltrials.gov confirms that this research is currently seeking volunteers. The trial was initially listed on January 10th, 2024, with the most recent update noted on April 17th of the same year. A total of 500 participants are being sought from two designated locations."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

EndeavorOTC® Research Study in College Students

2024. "EndeavorOTC® Research Study in College Students". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06376032.

All > Paid Studies Boston